slowed

Novartis IgAN data in New England Journal of Medicine show Fabhalta slowed kidney function decline by 49.3%

“Persistent kidney inflammation is a hallmark of IgAN, and a key driver of disease progression, leading to ongoing kidney damage…

4 hours ago